The German Heart Center Berlin performs the entire spectrum of cardiovascular and thoracic operations. It is one of the leading hospitals worldwide for the diagnosis and treatment of cardiovascular diseases.

Full article (in German)

The Fraunhofer MEVIS Institute for Medical Image Computing  Advisory Board has elected Prof. Dr. Hans Maier, BGM Associates, as its Chairman and Mr. Walter Märzendorfer, Siemens Healthineers, as its Vice-Chairman.
 
Fraunhofer MEVIS is a leading developer of medical software solutions for image-supported early detection, diagnosis, and therapy. Embedded in a worldwide network of clinical and academic partners, strong focus is placed on cancer as well as diseases of the circulatory system, brain, breast, liver, and lung. The goal is to detect diseases earlier and more reliably, tailor treatment to each individual, and make therapeutic success more measurable.

Link

Hans Maier was recently elected to the board of directors of Ascelia Pharma AB. The Malmö-based pharmaceutical company focuses on developing specialty oncological products.

Official press release

As part of its 5-year anniversary, BGM organised an evening boat trip along the river Spree in Berlin with business partners from Germany and abroad, as well as representatives from the healthcare industry and the medical-scientific community.

​We are excited to announce that Prof. Dr. Heinz-Otto Peitgen has joined our Advisory Board. Heinz-Otto Peitgen is Professor Emeritus of Mathematics at Bremen University and Florida Atlantic University where he served for more than three decades.

​A pioneer in the study of fractal geometry and chaos theory, Prof. Peitgen has been instrumental in the digital transformation of image based diagnostics and surgery. He is the founder of Fraunhofer MEVIS, Institute for Medical Image Computing, and co-founder of MeVis Medical Solutions AG, which was acquired by Varian Medical Systems Inc., Palo Alto, last year. It is great to have him on board as a sparring partner and thought leader in shaping medicine for the 21st century.

As of January 1st, 2016, BGM Associates Co-Founder Friedrich Gause became Managing Partner alongside Hans Maier. Friedrich Gause succeeds Gert Bruche who continues to serve the company in his role as a Partner.

Friedrich returns after a three-year period as interim COO of Piramal Imaging (PI), a molecular imaging startup. Following the spin-off of Bayer AG's molecular imaging assets into PI, Friedrich has driven the launch of PI's first PET tracer for the clinical evaluation of dementia & Alzheimer's disease and the buildup of the commercial organization and distribution network in the US, Europe and Asia/Pacific.

Profile of Friedrich Gause